1-833-663-7284 (Customer Support Available 24/7)
The Government of Canada is investing an additional $25.8M in research to continue global efforts to address the COVID-19 outbreak. This investment is just a small portion of the $275M in funding for research on medical countermeasures against COVID-19 announced by the Canadian Prime Minister on March 11, 2020. Cannalogue, a healthcare technology company that had received Health Canada’s first direct-to-sales license for medical cannabis – is seeking approval for clinical trials in a cannabis-based treatment for COVID-19.
Scientists have long investigated the immunomodulatory properties of cannabis. Some research suggests that THC and other cannabinoids are immune-suppressants — other studies, however, suggest that cannabis can boost the immune system by increasing white blood cell count in patients with immunodeficiency disorders such as HIV. Cannalogue is conducting a research study and hoping for a clinical trial in response to the call from Prime Minister Justin Trudeau for all Canadian businesses and innovators to stand united in the fight against coronavirus.
The specialists at Cannalogue believe the active medical ingredients from the cannabis plant could potentially boost the immune system to reduce the severity of symptoms from coronavirus. The trial is intended to assess if medical cannabis could mitigate the symptoms caused by COVID-19 infection or any mutant coronavirus strains. The company has launched a website for volunteers to apply in the event the clinical trial is approved by Health Canada.
Dr. Mohan Cooray, president and CEO of Cannalogue and a specialist in Internal Medicine, Gastroenterology, and Hepatology, said that while the company is “not suggesting with current knowledge of medical cannabis that it is a prevention, treatment or cure” of the disease, “plant cannabinoids have naturally occurring immunomodulatory properties that absolutely require expedited investigation given the current global COVID-19 pandemic.”
Clinical trials are conducted to investigate whether the use of a drug is safe and effective, what dosages are most effective, and what side effects may be associated with the use of the drug. Clinical trials require the informed consent of patients and enable the healthcare community to systematically collect information about the risks and benefits of the treatment. Health Canada is working to fast-track COVID-19 related clinical trials.
Cannalogue’s theory is if cannabinoid receptors are stimulated before infection, they may dampen the inflammatory response that follows, which is a key factor in the severity of symptoms observed in patients. Currently, there are no therapies available for either the prevention or treatment of COVID-19. While certain products may alleviate COVID-19 symptoms, such as fever and cough, there are no proven treatments to prevent or cure.
Health Canada is closely tracking all potential therapeutic treatments and vaccines in development in Canada and abroad, including products that are being used off-label. Cannalogue said that in support of the medical cannabis sector and scientific research community, it will release an exclusive insider health report that reveals key medical insights on emerging therapeutic areas with respect to medical cannabis.
In 2018, former President Donald Trump signed the Farm Bill into law. The Farm Bill is the federal government’s primary agricultural and food policy instrument. Every five years, Congress deals with renewing and revising the comprehensive bill. Before 2018, cannabis was not part of the conversation around farm subsidies or crop insurance. With the passing…
Four U.S. states—Minnesota, Ohio, Oklahoma, and Pennsylvania—stand a good chance at legalizing recreational cannabis this year. There’s also a slim chance of efforts being successfully voted on in the Carolinas, Indiana, and New Hampshire. Advocates are pushing harder for cannabis reform after achieving mixed results during last year’s midterm elections, which saw two victories (Missouri…
Nobody wants to spend time with paranoid Pete, but if you don’t choose your cannabis strains wisely, you could get flung into a portal of paranoia yourself. Funnily enough, a recent Marist poll found that almost a third of cannabis users in the U.S. use marijuana to ease anxiety or stress. A separate Marist poll…
Thursday, Jan. 26, 2023, will be a date to remember for cannabis lobbyists in Greece because, on this day, the first-ever medicinal cannabis production plant was inaugurated at Examilia in Corinth. Drizzled in seaside charm, Corinth is renowned for its ancient Roman remains and now claims the limelight as a medical marijuana production hub. Tikun…
Oklahomans’ cannabis vote ended on a sour note, a Canadian dispensary is facing backlash over cocaine sales, and Arizona law students are offering free expungement services. Let’s dive into this week’s cannanews. Oklahomans Vote on Cannabis Legalization Earlier this week, Oklahoma voters had a big decision to make on the ballot. Question 820 asked Oklahomans…
We’ve all been there. You take too many hits from a joint or too much of a potent edible, possibly not knowing…
Cannabis patients’ right to own a gun has been in question since cannabis legalization kicked off. Despite the fact that consumers of…
Vaping cannabis has increased in popularity over the last decade. It wasn’t long ago that many people weren’t familiar with vaping, but…
